Floatz logo

immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF4 (tumor necrosis factor receptor (TNFR) superfamily member 4, OX40, CD134)], Homo sapiens monoclonal antibody

Uterine Carcinosarcoma

HiFiBiO Therapeuticsmonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Uterine Carcinosarcoma cohort.

Asset / SponsorPhaseRating
Carboplatin
GOG Foundation
Phase 3B
Ifosfamide
GOG Foundation
Phase 3B
Niraparib
ARCAGY/ GINECO GROUP
Phase 2/3B
Dostarlimab
ARCAGY/ GINECO GROUP
Phase 2/3B
Sorafenib
National Cancer Institute (NCI)
Phase 2B

View all 14 →

Same molecule, other indications

immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF4 (tumor necrosis factor receptor (TNFR) superfamily member 4, OX40, CD134)], Homo sapiens monoclonal antibody is also rated in:

soft tissue sarcomaDormant
CC
Indicative ·
41 / 100
View asset →
renal cell carcinomaDormant
C
Indicative ·
37 / 100
View asset →
hepatocellular carcinomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →